Manuel Gómez del Moral

Universidad Complutense de Madrid — Spain

Immunology and Microbiology · Life Sciences

20h-index1.3kcitations63works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

T-cell and B-cell Immunology(11), Liver Disease Diagnosis and Treatment(10), Monoclonal and Polyclonal Antibodies Research(10), Immune Cell Function and Interaction(10), Immunotherapy and Immune Responses(9)

Publications63 total

Mesoporous silicon microparticles enhance antiviral immunity and memory responses against SARS-CoV-2
Scientific Reports·2026Open Access
Impact of High-Altitude Hypoxia on Mortality from Acute Lymphoblastic Leukemia in Mountain Regions of Ecuador
2025Open Access
Mesoporous Silicon Microparticles enhance robust immunity and protection against SARS-CoV-2 in mice and improves memory response in human PBMCs.
2025Open Access
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients
Vaccines·2025· 3 citedOpen Access
Comparative analysis of leukemia and risk estimation in working age population between provinces of Ecuador
Medwave·2024· 1 citedOpen Access
State of the Art in CAR-T Cell Therapy for Solid Tumors: Is There a Sweeter Future?
Cells·2024· 25 citedOpen Access
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
Cell Death and Disease·2023· 4 citedOpen Access
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress
Frontiers in Immunology·2023· 19 citedOpen Access
Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients
Frontiers in Immunology·2023· 8 citedOpen Access
Manufacture of Mesoporous Silicon Microparticles (MSMPs) as Adjuvants for Vaccine Delivery
Methods in molecular biology·2023· 2 cited
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
Cell Death and Disease·2022· 40 citedOpen Access
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
Cancers·2021· 38 citedOpen Access
Toward Sézary Syndrome immunotherapy
The Journal of Immunology·2021
Authoritative Education: The Recommended Practice for Educators
The Journal of Adventist Education·2021· 1 citedOpen Access
An Experimental DUAL Model of Advanced Liver Damage
Hepatology Communications·2021· 27 citedOpen Access
Intestinal Epithelial Cell-Derived Extracellular Vesicles Modulate Hepatic Injury via the Gut-Liver Axis During Acute Alcohol Injury
Frontiers in Pharmacology·2020· 29 citedOpen Access
Deletion of XBP1 in liver parenchymal cells ameliorates acetaminophen (APAP)-induced hepatotoxicity via activation of IRE1alpha-JNK1-ATG5-dependent autophagy
Journal of Hepatology·2020Open Access
Breaking barriers: Iberian Lynx Lynx pardinus Temminck, 1827 (Mammalia: Carnivora: Felidae) colonizing Olive groves
Journal of Threatened Taxa·2020· 10 citedOpen Access
THU-285-Loss of X-Box Protein-1 in intestinal epithelial cells promotes the development of alcoholic liver disease in the liver
Journal of Hepatology·2019
THU-072-N-ras protects against experimental liver fibrosis by maintaining hepatocyte homeostasis
Journal of Hepatology·2019
page 1 of 4Next →

Frequent Co-authors

Eduardo Martı́nez-Naves(24), Francisco Javier Cubero(9), Ángel Ezquerra(9), Javier Domı́nguez(9), Yulia A. Nevzorova(7), Fernando Sánchez‐Alonso(7), A. Zapata(7), Belén Álvarez(6), Kang Zheng(6), Javier Vaquero(6), Rafael Bañares(6), Beatriz Martín-Adrados(5), Juan López-Relaño(5), Luis Martı́nez Alonso(5), Arantza Lamas‐Paz(4), Rosario Bullido(4), Chaobo Chen(4), Iris Asensio(4), José R. Regueiro(4), Yolanda Campos‐Martín(4)